Q3 2025

Enhancing Adherence and Satisfaction with Disease-Modifying Therapies in Multiple Sclerosis Through Pharmacist-Led Interventions: Interventional Study

Zahraa Abbas Munaf · Samer Mohammed · Gheyath Abd Ali Shallal Al-Gawwam
10.35516/jmj.v59i3.3080 393 المشاهدات 0 الاقتباسات
0
الاقتباسات
393
المشاهدات
الملخص

Background: Pharmacists are essential in treating MS. Pharmacists' involvement and patient consultation may improve patient adherence and satisfaction.
Aim: To evaluate the influence of pharmacist-led interventions (PLI) on medication adherence and satisfaction in patients with multiple sclerosis receiving disease-modifying therapies (DMTs).
Methods: This study was conducted on patients with relapsing-remitting multiple sclerosis who were receiving DMTs and attended a neurological consultant clinic in the medical city of Baghdad. It was a pre-post-intervention study. Each patient underwent two educational sessions: the first session took place at the beginning of the study, after completing the Arabic version of the treatment satisfaction questionnaire for medication (TSQM-14item) and the Arabic version of the Morisky, Green, and Levine (MGL-4item) medication adherence scales. The second session occurred one month later. The duration of each session ranged from 30 to 45 minutes, during which the patients received educational counselling. Each patient was provided with a formal Arabic pamphlet. This pamphlet contained medical information about the disease and treatment. Subsequently, after two months, the patient completed the identical questionnaires once again.
Results: The participants' average age was 30.64±8.54. PLI had a substantial positive effect on adherence levels, but it did not have a significant impact on medication satisfaction. Significant variations in the educational level and type of treatment were only observed in the changes in treatment satisfaction scores. The degree of response to PLI was not correlated with sociodemographic factors.
Conclusion: The implementation of an educational intervention led by a clinical pharmacist can enhance the adherence of patients with multiple sclerosis; however, the change in treatment satisfaction scores was only a minimal change.

الاستشهاد بهذا المقال (APA)
Zahraa, A. M., Samer, M., Gheyath, A. A. S. A. (2025). Enhancing Adherence and Satisfaction with Disease-Modifying Therapies in Multiple Sclerosis Through Pharmacist-Led Interventions: Interventional Study. Jordan Medical Journal. https://doi.org/10.35516/jmj.v59i3.3080
أبحاث ذات صلة
16
استشهاد
397
The Future of Pediatric Care: AI and ML as Catalysts for Change in Genetic Syndrome Management
Lama Ghunaim; Ahmed S.A. Ali Agha; Ali Al-Samydai; Talal Aburjai · 2024
15
استشهاد
395
Evaluation of Artificial Intelligence-Based Chatbot Responses to Common Dermatological Queries
Indrasish Podder; Neha Pipil; Arunima Dhabal; Shaikat Mondal; Vitsomenuo Pienyii · 2024
6
استشهاد
398
Investigation of MicroRNA 196a2 polymorphism with Thalassemia Disease among Middle and South Iraqi P…
Ahmed Al Shammari; Zahraa Isam; Thikra Banimuslem; Ahmed Neamaa · 2025
5
استشهاد
389
Enhancing Security and Privacy in Healthcare with Generative Artificial Intelligence-Based Detection…
Yasmin Makki Mohialden; Saba Abdulbaqi Salman; Maad M. Mijwil; Nadia Mahmood Hus · 2024
5
استشهاد
391
الوصول
عرض النص الكامل عبر DOI
نُشر في
الرقم الدولي ISSN 0446-9283
الربعية Q3
درجة المؤشر القياس العربي 67
التخصص Medicine & Health Sciences
الناشر Jordan Medical Association
الدولة 🇯🇴 Jordan
عرض ملف المجلة →
المؤلفون
تفاصيل النشر
السنة 2025
اللغة English/Arabic
أُضيف في 24 Jul 2026